India to Australia: Doxorubicin Export Trade Route

The India to Australia Doxorubicin corridor is one of India's established pharmaceutical export routes, with 27 shipments documented worth a combined $1.6M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's doxorubicin manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $59.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 19.2%, placing it at rank #3 among India's top doxorubicin export destinations globally.

On the import side, key buyers of Indian doxorubicin in Australia include SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD , SUN PHARMA ANZ PTY LIMITED and 9 others. SUN PHARMA ANZ PTY LTD is the single largest importer with 4 shipments valued at $645.8K USD.

India's doxorubicin exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $59.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as liposomal doxorubicin sun 20 mg/10 ml pa and liposomal doxorubicin sun 50 mg/25 ml pa , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SUN PHARMA ANZ PTY LTD is the largest importer with 4 shipments worth $645.8K USD — representing 40% of all doxorubicin imports from India on this route. A total of 12 buyers are active on this corridor.